Add BrightSurf on Google Email

University of California - San Francisco


Scientists find protein can protect new blood vessels from leaking ---promising complement togrowth stimulant VEGF

Researchers at UCSF and Regeneron Pharmaceuticals have found that the protein angiopoietin-1 (Ang1) can restore leaky vessels to normal, block leakage effects of substances, and complement VEGF's growth-promoting action. This discovery holds strong promise for treating chronic inflammatory diseases and promoting healthy blood vessel gr...

Physicians who compassionately ask about domestic violence can elicit positiveoutcomes, UCSF study shows

A UCSF study found that physicians who ask victims of domestic violence if they are being physically abused can provide the first step towards helping them find a way out. The study showed that a validating and gentle approach, rather than seeking a yes or no answer, is more effective in identifying victims and providing support.

SourceUniversity of California - San Francisco·JournalAnnals of Internal Medicine·DateOct 18, 1999

Clinical trial demonstrates that bone marrow transplant followed by vitamin A-derivative treatment improves survival from a major childhood cancer

A randomized clinical trial showed that combining bone marrow transplant and high-dose chemoradiotherapy significantly improves disease-free survival in children with neuroblastoma. The addition of vitamin A-derivative treatment further increases survival rates by nearly three-fold.

SourceUniversity of California - San Francisco·JournalNew England Journal of Medicine·DateOct 14, 1999

Scientist show how viruses co-opt cell defenses to cause chronic infections likethose from HIV and Hepatitis B and C

Researchers have developed a model to study viral evasion and co-option of cellular defense strategies, revealing that persistent infection is achieved by suppressing cell suicide. Physiological changes occur, including slower growth and reduced virus infectivity over time.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateOct 11, 1999

UCSF breast cancer expert collaborates with Dalai Lama's doctor in Tibetan medicine study: Women needed to participate in trial

A clinical trial is underway at UCSF to test the effectiveness of traditional Tibetan medicine as a sole therapy for advanced breast cancer. The trial, led by Yeshi Dhonden and Dr. Debu Tripathy, aims to evaluate the impact of individualized herbal therapies on tumor size in women with stage IV breast cancer.